Clayton co-founded Novel Therapeutics and directs phytochemical R&D at REG, where he runs an AI-driven pipeline that discovers and optimizes plant-derived molecules for cancer therapeutics. His work combines deep phytochemistry expertise with computational drug design to develop safer, naturally-derived alternatives to conventional chemotherapy, with a primary focus on adenocarcinoma lung cancer.

Chris is a Ph.D. candidate at Texas A&M and leads REG’s work in polyploidy and phytochemistry. With a background in biomedical science and chemistry, he focuses on enhancing hemp through induced polyploidy and phytochemical analysis to support innovations in agriculture and therapeutics.

Teja holds a Master’s in Plant Breeding from Texas A&M and leads projects on heat-tolerant and cannabinoid-free hemp. She helped launch a global research partnership with India’s CSIR-NBRI and brings strong technical and communication skills to REG’s innovation efforts.

Aseem is an entrepreneur with a background in mechanical engineering and a passion for cross-sector innovation. He has worked in agriculture, energy, and the arts, bringing a global perspective to problem-solving. A lifelong learner, Aseem helps guide REG’s vision and strategy.

Alex brings expertise in project management, fundraising, marketing and branding, combined with a decade of experience building startups across multiple industries and continents. He coordinates our efforts of turning novel ideas into promising companies.

John’s extensive hemp industry expertise spans sales, cultivation, processing, and facility management. John oversees our College Station facility and coordinates all hemp breedings projects.

Ezekiel is pursuing his Ph.D. in Plant Breeding at Texas A&M University's Industrial Hemp Program. He combines academic rigor with extensive cultivation experience to develop novel varieties with diverse industrial and therapeutic applications.

With dual degrees in Horticultural Sciences and Plant & Environmental Soil Sciences, MJ's expertise spans greenhouse, indoor, and field production, genetic analysis, and biotechnology applications.

Josh has developed novel protocols to extract cellulose nano-crystals, with applications as composite strengtheners and Pickering emulsifiers. His work advances our mission to create sustainable, high-performance materials. Josh is currently pursuing his Ph.D. in the Molecular and Environmental Plant Science program at Texas A&M University.

Dr. Jessup brings deep plant science expertise as Professor and Center Director at Texas A&M AgriLife, serving as Chief Scientific Officer at Rare Earth Genomics to guide innovation across our project portfolio.

Calvin brings three decades of experience executing complex, large-scale projects across North America, Africa, and the Middle East for multinational corporations, including Royal Dutch Shell.

Andrei brings experience spanning startups to 10,000+ employee industrial operations. He combines business acumen with deep expertise in AI, software, and emerging technologies to lead REG and its portfolio companies.

Mason Berry founded Rare Earth Genomics in 2019 with the vision of turning it into an incubator for cutting-edge research in agritech and life sciences.

A Texas A&M alumnus in Plant & Environmental Soil Science, Ian co-invented the W3 formulation and has guided it to TRL-5. His portfolio spans product chemistry, entomology, EPA data, and multi-crop phytotoxicity testing.